CARIM's PhD programme is accessible for talented and motivated students that are graduated from national and international Medical and Biomedical Masters. Currently approximately 100 PhD candidates are enrolled in our PhD programme. Almost 50% of our PhD candidates come from foreign countries, guaranteeing an international atmosphere. In general, PhD candidates are selected through open competition when there is a vacancy.
The principal goal of the 4-year PhD training programme is to support PhD candidates in developing themselves into independent and productive researchers in the cardiovascular field. To ensure high quality PhD training, CARIM offers frequent interaction of PhD candidates with a skilled and experienced supervisory team, thereby providing a stimulating and critical environment to further develop one's research skills. We also offer our PhD candidates a broad range of possibilities to attend seminars, master classes, and symposia to present their own research on national and international podia.
- CARIM PhD Guide
- PhD Coordinator: Prof. Eline Kooi
- PhD at FHML/MUMC+
- Scientific integrity
- PhD support UM
- Guidelines – CARIM Training & Development plan
CARIM organises several state-of-the-art cardiovascular courses for PhD candidates within one week in parallel. This so-called CARIM Course Week not only encompasses cardiovascular courses, but also includes a joint programme as well as various social activities co-organised by I'M CARIM, our PhD club.
The CARIM Courses allow you to become acquainted with state-of–the-art technologies and novel concepts in Cardiovascular Research. Equally important, it allows you to meet fellow PhDs and CARIM staff. This will help you to generate new ideas, to boost your own research, and to enlarge your network.
- Heart Failure Research
- Non-Invasive Cardiovascular Imaging
- Drug Development
- Vascular Inflammation and Thrombosis
The Department of Molecular Cell Biology organises the course 'Advanced Optical Microscopy'. This course also counts as a CARIM course.
This year, the CARIM Courses are scheduled in two weeks: week 1 from 12-16 June and week 2 from 19-23 June. The courses are:
- Maastricht Microscopy Meeting on Advanced Optical Microscopy (12-16 June)
- Heart Failure Research (12-16 June)
- Non-invasive Cardiovascular Imaging (19-23 June)
Dutch Heart Foundation PhD courses (Papendal courses)
The cardiovascular PhD-training courses consist of 3 state-of-the-art courses. These are organised under auspices of and with financial support from the Dutch Heart Foundation. All three courses take 5 days and take place at the Papendal conference Center in Arnhem in or around October. The courses are open not only to CARIM PhD candidates but also to PhD candidates of other Dutch universities and research institutes. The Papendal courses address three topics, corresponding with the CARIM research themes: Cardiac Function & Adaptation, Vascular Biology, and Thrombosis & Haemostasis. For detailed information on the contents of the Papendal courses and how to apply click here.
Concerns & Complaints Point
The Concerns & Complaints Point is a central point for concerns, questions, reports and complaints that affect a socially safe working and learning environment. Within the CCP, a social safety team has been appointed. This team is impartial and independent, it offers you a listening ear, a sparring partner, and together with you searches for a good path for your question.
Together with you, the CCP will look for a way to move forward. If you contact the coordinator of the CCP, there is always a colleague available who knows the formal and informal routes within UM, and who will help you find the best way to deal with your question, concern, report or complaint. Of course, you can also come to the CCP if you just want to get something off your chest. Interviews with the CCP coordinator are confidential.
Dissertation award 2021
Dr Job Verdonschot (Dept. of Cardiology) received the CARIM Dissertation Award 2021 for his thesis ‘Causes and Consequences of Dilated Cardiomyopathy: Integrating Genotype and Phenotype to Redefine Disease Diagnostics and Therapeutics’.